#generic-drugs

[ follow ]
#patent-law
Alternative medicine
fromPatently-O
4 months ago

Generic Drugs, Skinny Labels, and Liability for Off Label (Infringing) Use

Hikma's petition seeks clarification on generic drug marketing liability regarding 'skinny labels' under patent law.
Alternative medicine
fromPatently-O
4 months ago

Generic Drugs, Skinny Labels, and Liability for Off Label (Infringing) Use

Hikma's petition seeks clarification on generic drug marketing liability regarding 'skinny labels' under patent law.
more#patent-law
fromIPWatchdog.com | Patents & Intellectual Property Law
1 week ago

SCOTUS Asks SG for Input on Petition Seeking to Clarify Inducement Under Hatch-Waxman

"Hikma's petition highlights serious concerns regarding the implications of the CAFC's decision, portraying it as a significant shift that undermines the generic drug expediting process."
Intellectual property law
#pharmaceuticals
US politics
fromTruthout
2 months ago

Tariffs on Pharmaceuticals May Be the Next Front in Trump's War on Public Health

Trump's proposed tariffs on pharmaceuticals could lead to higher costs and shortages of medications for U.S. patients.
Intellectual property law
fromPatently-O
3 months ago

Tax Victory for Generic Drug Companies: Federal Circuit Affirms ANDA Litigation Expenses are Deductible

Generic pharmaceutical companies can now deduct legal expenses from patent litigation as ordinary business expenses.
US politics
fromTruthout
2 months ago

Tariffs on Pharmaceuticals May Be the Next Front in Trump's War on Public Health

Trump's proposed tariffs on pharmaceuticals could lead to higher costs and shortages of medications for U.S. patients.
Intellectual property law
fromPatently-O
3 months ago

Tax Victory for Generic Drug Companies: Federal Circuit Affirms ANDA Litigation Expenses are Deductible

Generic pharmaceutical companies can now deduct legal expenses from patent litigation as ordinary business expenses.
more#pharmaceuticals
Medicine
fromwww.nytimes.com
9 months ago

Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries

Gilead aims to broaden access to lenacapavir through generic production in low-income countries but excludes middle-income nations, highlighting healthcare disparities.
[ Load more ]